CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 2)
Clinical trial NCT02053610 · COMPLETED
Trial details
- NCT number
- NCT02053610
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-31
- Primary completion
- 2013-08-31
- Enrollment
- 787
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.